claims Tagged Articles
Serious bleeding events associated with blood thinner Pradaxa
Just a year after the Food and Drug Administration (FDA) approved Pradaxa (dabigatran) to prevent blood clots in patients with a life threatening type of irregular heartbeat known as atrial fibrillation, the agency announced it was looking into reports of
Study investigates bleeding deaths associated with blood thinner Pradaxa
The death of Bob Smith* was a surprise to doctors. The 83-year old man was evaluated for what appeared to be a rather routine fall, and by all accounts he seemed fine. He was fully alert and oriented and could
Bayer settles a small fraction of Yaz, Yasmin lawsuits
Bayer has agreed to settle about 70 of the approximately 11,300 lawsuits against the drug giant involving its blockbuster birth control pills Yaz and Yasmin, according to the company’s 2011 annual report. The terms of the settlement were not disclosed,
Study finds Pradaxa could make common falls lethal for elderly
The death of an 83-year-old man who checked into The University of Utah’s hospital after suffering from a routine fall raises concerns that hemorrhaging may be irreversible in patients taking Boehringer Ingelheim’s blood-thinning drug Pradaxa.
Whistleblower sues Takeda for downplaying Actos heart risks
A U.S. unit of Japan-based Takeda Pharmaceutical Co. downplayed the seriousness of hundreds of cases of congestive heart failure linked to its diabetes drug Actos to federal regulators, a Takeda employee alleges in a whistle-blower lawsuit she brought against the
Blood-thinner Pradaxa linked to uncontrollable bleeding, death
Concerns about prescription blood-thinning medication Pradaxa increased recently, when a Utah man died within hours after falling and hitting his head. Doctors discovered he was hemorrhaging in his brain and could not stop the bleeding. The man had been taking
FDA rejects Merck’s new combo cholesterol drug
Merck & Co. will have to provide more data on its experimental cholesterol-lowering drug cocktail before the Food and Drug Administration (FDA) will allow it to be sold in the United States. The drug, known only as MK-0653C, is designed
Whistleblowers key in the fight against fraud
Whistleblowers have become one of the federal government’s most valuable tools in its ongoing efforts to crack down on corporate wrongdoing and recover money lost to overbilling and other fraudulent activities.
BMJ confirms FDA’s warning that SSRIs can cause birth defects
In January, the British Medical Journal reaffirmed a U.S. Food and Drug Administration (FDA) warning when it published a study that showed a class of antidepressants known as selective serotonin reuptake inhibitors (SSRIs), were linked to serious birth defects in
